Siveke, J T <br/><br/>
Biological response modifiers for the treatment of Crohn's disease.  [electronic resource] 

 -  Expert opinion on biological therapy  Nov 2004 
 - 1719-27 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7682 
<br/><br/><label>Standard No.: </label>10.1517/14712598.4.11.1719  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--therapeutic use<br/>Cell Adhesion--drug effects<br/>Cell Adhesion Molecules--antagonists & inhibitors<br/>Clinical Trials, Phase III as Topic<br/>Crohn Disease--drug therapy<br/>Cytokines--antagonists & inhibitors<br/>Dehydroepiandrosterone Sulfate--therapeutic use<br/>Drug Evaluation, Preclinical<br/>Growth Substances<br/>Humans<br/>Immunologic Factors--therapeutic use<br/>Immunosuppressive Agents--therapeutic use<br/>Lymphocyte Activation--drug effects<br/>Mice<br/>Randomized Controlled Trials as Topic<br/>Remission Induction<br/>T-Lymphocytes--drug effects<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors